Hmmmm. I know you still think the Vulvo issue has not been put to bed. But why would Arna not at least take the recommendation and do the 12 month rat study? Isn't that just asking for trouble. Maybe Herper is right and Lief needs to go. Seems to me that would be the best idea, especially in light of Contrave's beat down.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.